[Canakinumab, a monoclonal antibody against IL-1β, with potential utility in different inflammatory processes]. [electronic resource]
Producer: 20110816Description: 34-7 p. digitalISSN:- 1578-8989
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Carrier Proteins -- genetics
- Clinical Trials, Phase III as Topic -- statistics & numerical data
- Cryopyrin-Associated Periodic Syndromes -- drug therapy
- Disease Susceptibility
- Half-Life
- Headache -- chemically induced
- Humans
- Infections -- etiology
- Inflammation -- drug therapy
- Interleukin-1beta -- antagonists & inhibitors
- Multicenter Studies as Topic -- statistics & numerical data
- NLR Family, Pyrin Domain-Containing 3 Protein
- Up-Regulation
- Vertigo -- chemically induced
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.